Did I Choose the Wrong Profession? 

Amy Beausang, PharmD, RPh
28
564

After 7 years of university (5 in pharmacy school), and just 6 months after passing my pharmacy board exams, the sickening realization that had been creeping up out of my gut–the one that I kept trying to hide from my brain and my heart–could be repressed no longer.

I stood in the middle of another 16-hour shift as pharmacist on duty at CVS desperately wishing I were anywhere but there.  Emotionally and mentally fried already at the ripe old age of 25, I didn’t want to take another doctor’s call. Or spend another half hour on the phone with some insurance company in efforts to find out which cholesterol medication WAS actually covered by the patient’s plan. My skin hadn’t toughened up enough yet, because snide comments from some customers about my slowness, or my failing to know that they ALWAYS get brand, and NEVER generic, began to get to me. Didn’t I know that generic antibiotics don’t work as well as brand?

And I loved it when people would ask me if they could talk to the “actual” pharmacist. They couldn’t believe that I was an actual pharmacist. (OK, so I did look more like a 14-year-old when I was 25, which is not a good thing when you’re a woman trying to be taken seriously as a professional). Often, customers thought the 18-year old, 6’5”, male pharmacy technician better fit the bill.  Sometimes I was so tempted to just let him advise them on how to clear up that angry rash on their nether-regions. I vividly remember when it was just me behind the counter, apologizing for the wait that would surely melt the ice cream that they left in their hot car in mid-July while they “ran in” to get three new prescriptions filled. Seven years of study for this?

Pharmacy school means semester after semester of medicinal chemistry, pharmacokinetics, pharmacology, pharmacy law, practical labs, pharmacotherapy, and clinical rotations. Summers working in various pharmacy settings to gain practical experience in patient care. Years of studying mechanisms of disease and mechanisms of action, appropriate dosing, drug interactions, efficacy, safety, side effects, absorption, distribution, metabolism, elimination. Years of learning how medications can alleviate symptoms, cure infections, prevent heart attacks, slow cancer progression, and yes, “correct chemical imbalances.” And lots of practice counseling patients on their medications, and the importance of adhering to those medications.

What I really wanted to do was to educate people about their medications–and to find out more about why they actually needed them in the first place. Most of all, I wanted to live up to the profession of pharmacy as one of the most trusted and respected professions—a ranking that still holds true according to a 2014 Gallup poll. But deep down I felt like my work made no difference, and I was terribly disappointed that I had worked so hard for a job I despised.

After a few more months I was a burned-out pharmacist who hadn’t even made it a full year in the workforce. Finally, after much searching, I happened to find what sounded like the perfect job as a member of the first Medical Science Liaison team at a major pharmaceutical company. Just a few years previously, that same company had flown my entire pharmacy school class of 150 to its US headquarters so that we could marvel at the inner workings of the industry. It was truly amazing. We learned how recombinant human insulin was made using bacteria housed in giant fermentation vats and watched a movie about revolutionizing the treatment of type 1 diabetes. And we saw thousands of blockbuster-antidepressant-filled capsules cruising towards stock bottles on assembly lines.  The dream of one day working for a company like this was happening for me!

If you Google “Medical Science Liaison” or “MSL,” you can get a pretty good picture of what the role entails. You’ll also see that there is an actual MSL Society with its own journal, and an MSL Institute. The MSL concept has been around since the late 1960’s–Upjohn is credited with its creation. Only in the last couple of decades, however, has the MSL role really exploded. With increasing restrictions on sales representative activity and accessibility–imposed by both regulatory agencies and also by individual clinical practices and institutions–MSLs are more important than ever.

MSLs are medical professionals typically with PharmD, MD, or PhD degrees who work in “Medical Affairs” departments at pharma and biotech companies. They are not to be associated with sales and marketing.

We struck a non-promotional tone. We were to never use brand names and were not allowed to use “detail aids”, those beautiful, art-directed layouts used by sales reps.. Instead, MSL’s used articles published in “respected” journals, or abstracts from scientific meetings, or other “unbranded” resources.

Many job descriptions state, “MSLs utilize their deep therapeutic area expertise to respond to unsolicited requests for medical/scientific information received from research physicians and other health care professionals”. So it was perfectly legal for me, as an MSL, to speak to our customers about “off-label” information, or to chat about the latest studies or emerging trends, or to share (or even create) slide presentations that contained information that would be proscribed for the sales and marketing teams. So, who were these customers I was “targeting”?

They were an elite set of physicians deemed worthy of special attention–the Key Opinion Leaders (KOLs) in their fields. KOLs are so designated because their opinions influence the masses of practicing physicians, i.e. the “prescribers” who ultimately help determine market share.

Imagine a triangle of influence. At the base are prescribers and as you work upward, there are local KOLs, then regional KOLs. And finally, there are national and international KOLs who are the “global influencers”. As you climb the tiers, the KOLs decline in number, but increase in power. It is impossible to overinflate the importance of KOLs to pharma and biotech companies. There are entire agencies for hire that focus on “KOL identification and influence mapping”.  For example, one such agency offers services that enable KOL influence to be evaluated on size (how many peers may be reached) and depth (to what degree each KOL influences peers)”. This agency’s website explains, “aligning with KOLs who possess reputational expertise and an expansive sphere of influence will maximize your marketing investment.” When gauging the level of “KOL-ness”, one typically considers journal publication history, association strongholds, board spearheading, and speaking at major association meetings. There are also efforts to identify “rising stars” that could potentially be molded into advocates for the company’s brand.

The job of an MSL is to build relationships with regional and national KOLs. I would fulfill information requests from KOLs in order to get my foot in their doors because these physicians are rarely accessible to sales reps. The real value of MSLs lies in their ability to gain insights that help inform the company’s strategic directions for research and commercialization. MSLs can also get leads on competitors and therapeutic market trends if they’re clever enough. The hope is that your company’s MSLs become a favorite of those KOL targets so that they will turn to you first when they need something from industry. The hope is that your MSLs become that bridge to the great sphere of prescribing influence.

MSLs can be aptly described as pharma and biotech’s “special forces” almost analogous to drones because they are highly trained and equipped to go where few can go, and to capture really valuable “intelligence” for their companies. A drug doesn’t even have to be FDA-approved before MSL deployment. Once it hits Phase III clinical trials and sometimes even earlier, companies dispatch MSL teams to forge those powerful relationships.

Alas, I was not a great forger of KOL relationships. No surprise, really, as I am quite the introvert. My schmoozing skills were pitiful at best. I had the knowledge to share, but just didn’t have the knack for getting a KOL to spill the beans, or for instigating some stellar idea for research collaboration. My compassionate boss soon realized this, and in a very tearful meeting in a crowded airport, she offered me the chance to create an “internal MSL” position of sorts. Thank heavens I wasn’t getting fired.

In my new role, it was awe-inspiring to pull into the parking lot of my company’s national headquarters everyday. There was a majestic fountain. I could always smell something “cooking” as I trekked from my far away parking space to the main entrance. I liked to think it was the insulin-producing bacteria in those big vats, because the odor had a sort of fermented note to it. I was largely responsible for developing the curriculum for MSL training sessions, so I was constantly scouring the medical literature and meeting with company physicians and team leaders so that I could keep the field MSL team up to date.

I began to learn much more about branding and marketing. Terms like “total Rx volume,” and “message retention” became familiar. I was the interface between marketing and the MSLs so that their strategies with KOLs would align more with the strategies of the brand’s marketing team. I attended meetings of major medical associations to score competitive intelligence and to hear about therapeutic trends. I went to the company’s KOL advisory board meetings which were always at fabulous locations. During incredible 3-hour dinners, I would hear quite a lot of valuable information from KOLs.

In years past, pharma companies were allowed to hold “market research” meetings that targeted top-prescribing physicians in a particular therapeutic category. Again, these were always held at desirable destinations, and the attendees were invited to bring their families along, which most did. Several hundred physicians would arrive to a lavish welcome reception on Friday evening, and then attend “working sessions” for about 5 hours on Saturday and 3 hours on Sunday. Activities at theme parks or other attractions were provided for spouses and kids while the doctors were in session.

During these sessions, company physicians would present mostly off-label, unpublished, and “confidential” data and then ask very strategic questions, with answers from each attendee collected via hand-held audience response systems. What was billed as a market research endeavor was really a clever way to legally provide off-label information about a brand-name medication to physicians who could otherwise not receive it. And more importantly to find out how that off-label information influenced prescriber perceptions about the drug. How likely would this information shift their prescribing habits away from the top competitors in the market and toward our brand? At the time, I was entrenched in the culture, and just thought it was part of the job and I truly believed the drugs we brought to market were helping people.

Or maybe they weren’t. But I wasn’t quite ready to really admit that, yet.

Fast forward to December 2001 when I moved to New York and landed a position as “Vice President, Associate Medical Director” at one of the top pharmaceutical advertising agencies in the city.  While my prior experience at a pharmaceutical company was eye opening in terms of how the industry worked, I’d have to say that my time on the “agency” side– now serving those clients–was positively mind-blowing.

At first, agency life felt so glamorous! Advertising is all about image, even in the healthcare realm. When I stepped off the elevator to my 9th floor office (which happened to be conveniently facing Pfizer US headquarters across the street), I walked into a polished, super sleek reception area, with attractive receptionists and beautiful, giant bouquets of fresh flowers. Award-winning agency work lined the walls. If we had to work late, private cars were called. If we flew further than 3 hours, it was in business class. We took clients to posh dinners when they were in the city on business. No expense was spared. After all, the clients were spending a boatload of money on us. How much during my time there, I’m not sure. According to Medical Marketing & Media’s report on the top 100 agencies’ revenue rankings for 2014, the agency group that I worked for generated at least $250 million. That’s not surprising when you consider that each person working on a particular brand is operating at billable rates ranging from $100 to $500+ per hour. And there are lots of people working on big brands at any given moment and usually for LOTS of hours.

As a medical director, I was assigned to specific brands. I helped copywriters and art directors create a credible and accurate “story” for those brands, and also helped craft hundreds of “key messages.” I wrote speakers’ notes for presentations given by outside physicians paid to “educate” health care professionals at dinner symposia, helped art directors bring a product’s mechanism of action to life, sat in countless brainstorming sessions on how to “grow the market.” I helped identify “unmet needs” in the treatment of a particular disease, and helped highlight the “limitations of current therapy” if our brand was on the cusp of regulatory approval. I delved into “pipeline analyses” to stay abreast of pending competition. I occasionally participated in publication planning, a process of mapping out which medical meetings and prestigious journals would best serve the brand, although this service wasn’t my focus. But I was involved enough to know all about “ghost writing.” Overall, this position suited my skillset, and in a surprisingly creative sort of way.

Thinking back, it was, in reality, too creative. Reading Robert Whittaker’s Anatomy of an Epidemic for the first time really reminded me of this fact.

There is one sentence in chapter 4 of Anatomy that sums up much of the work I saw–and participated in–during my agency life. Although I worked very little on psychiatric drugs, this excerpt from Mr. Whitaker’s book applies to virtually any drug category:

“All that was missing from this story of magic-bullet medicine was an understanding of the biology of mental disorders, but with the drugs reconceived in this way, once researchers came to understand how the drugs affected the brain, they developed two hypotheses that, at least in theory, filled in this gap.”

In the ad agencies where I worked, we were constantly retro-fitting.

In essence, this is how we approached our work: “Here are the clinical data for Brand X. Now how do we create a story that makes these results extremely relevant and valuable to prescribers and patients?” Even with disappointing clinical data, or data that really isn’t relevant, it’s not that hard to tell a compelling story–one which really provides that all-important “reason to believe” that Brand X is the best option available. Highly respected journal publications are often pulled together to validate and lend credibility to the story that’s been crafted. Our goals were to prove that unmet needs existed, to highlight shortcomings of current therapies, and to provide rationales for why Brand X show promise as a “novel” treatment for a given condition.

One of the key roles of an agency medical director is helping win new business. As in other advertising fields, this process is called “pitching.”  We’d pitch our ideas for branding, campaigns, and driving market growth in the hopes of wowing potential new clients. Pitches are competitive, grueling, time-consuming and expensive. Usually, 4 to 5 agencies are each spending hundreds of thousands of dollars to vie for the prize. And after all that time and money is spent, there’s a good chance your agency won’t even make the cut. But it’s a risk worth taking to gain multi-million dollar accounts.

Once the pitch was a “go,” I immediately began setting up interviews with national and international KOLs, because the brand “story” we would create hinged largely on what we learned from them. The agency where I worked for most of my career built an impressive “KOL database” that captured everything we needed in order to identify the best consultants for a particular pitch. I would interview and pay 10 to 20 KOL so we could better understand the hot topics and trends in the field, how they thought Brand X would be positioned among the current treatments, what its potential opportunities and challenges would be. What we really wanted, however, were compelling quotes from those influential KOLs to plug into our pitch, to really make our “validated” story sing, and to wow the potential client with how smart we already were about their brand and the market overall. This illustrated how connected we were with the major influencers in the arena. And it was highly successful. Potential clients LOVE to hear KOLs say great things about their impending products. And KOLs help create great brand stories, whether they are fully aware of it at the time, or not.

Once we won the business, it was time to get to work bringing the brand to life. And for some products, this would begin a year or more before the drug was even approved by the FDA. If a product works in a “novel” way, there’s a lot of groundwork to be done to educate KOLs, prescribers, and other stakeholders about the science behind that new mechanism of action. There’s a lexicon to build, a status quo to challenge, and a new standard of care to envisage. A great way to achieve this is through “advertorial”-type pieces—a blend of advertisement and tutorial–disseminated through various channels before launching a new product to market. Advertorials are not designed to hard-sell a brand. They’re similar to a news article, but also include elaborate illustrations and detailed stories. Advertorials are scientific and educational in nature and are used to communicate an unmet need within a category, increase disease state awareness, influence or change a treatment paradigm (i.e., point out why current treatment options are inadequate), or explain a new mechanism of action (MOA).

When the “pivotal” (i.e., FDA-approval data) finally become available, many brains are working on how to best depict that data in the most compelling way. Some brands are easier than others. If we had to work with less-than-impressive clinical data, we could stretch a y-axis like nobody’s business. If Brand X reduced an event (like an asthma attack) from 0.4 events to 0.2 events, we made the y-axis go from 0.0 to 0.5. That seemingly minor reduction now looked pretty significant in a detail aid, especially when weaved in with compelling messages and story flow. And in some situations, we could get away with translating that 0.4 to 0.2 reduction into a whopping “50% reduction in relative risk.” This likely comes as no surprise, as we see this over-inflation of drug-induced benefit all the time–even in reputable sources like medical journals.

We are all familiar with the arguments that companies spend billions of dollars to bring a drug to market, that it takes at least a decade of research, and that thousands of entities never even make it to human testing. All of these points are used to justify skyrocketing drug costs in the name of altruistic endeavors such as “Working for a Healthier World” or “Where Patients Come First.” (These are actual company slogans.) What I’ve seen and participated in during my time in the industry is that patients really don’t come first.

The brainstorming sessions are never really about bringing value to the patient, even when that’s the big, bold agenda on the whiteboard. It’s about bringing “value” to the patient so that more prescriptions will be written, leading to bigger market share. It’s not really about improving patient outcomes. It’s about making the outcomes data look as compelling as possible so that more prescriptions will be written, leading to bigger market share. It’s not really about the company footing the $250,000 bill when the patient with the rare genetic disorder just can’t afford the medication. It’s about improving optics so that you can actually justify charging that much for a necessary medication in the first place, when its extremely similar predecessor costs 97% less.

It’s not really about patient tolerability, even though many patients in the real world stop taking drugs due to intolerable side effects.

Statin drugs are, in fact, a perfect example of the dynamics involved here.  At one point, the industry claimed that most large, randomized, placebo-controlled trials just didn’t show that statin intolerability was really a problem—because at the time it wasn’t in the best interest of big statin brands to acknowledge it. But now, because almost all statins have gone generic, and other companies are racing to market with a “novel” class of cholesterol plummeters called PCSK9 inhibitors, it is finally time to tell the truth about statin intolerance. Now we see KOLs and publications highlighting the major limitation of statins–those intolerable side effects that for years were largely deemed a product of patients’ imaginations–and establishing a real unmet need, and spending millions of dollars to do big studies to prove just how intolerable statins REALLY are for a substantial subset of patients, compared to the potential new blockbuster.  All of this is to sell the story that the $15,000 per year price tag is well worth it, compared to $100 to $200 per year for a generic statin.

Most pharmacists I know have hearts of gold and wholeheartedly want people to feel better and to be healthy and have longer, happier lives, and they see medication as a way to help people achieve those things. I know this because I was that person, too. I’m not saying that my post applies to every drug ever developed. I know there are some medicines that have truly saved lives. But I believe that far too many are making people worse, or at best are just covering up symptoms rather than addressing the roots of the problem.

I no longer work for the industry, and I’m never going back. When I learned about Mad In America and people like Robert Whitaker, Dr Irving Kirsch, Dr David Healy, and Dr Peter Breggin, I felt encouraged. All of these resources are confirming what I began to realize several years ago. Psychiatric drugs (and other over-prescribed drugs like statins and proton pump inhibitors) certainly don’t really fix us, and they often harm us.

I will soon be working as a health coach on a mission to help women in particular avoid, reduce, and potentially eliminate prescription medications. It’s quite a change in trajectory, especially for a pharmacist–we’re typically counseling people to take their medications. But I feel like I’ve come full circle, and I am grateful for my time in the industry. Without it, I may never have seen the way things actually work, which is now empowering me to inform people about their medications–to help them weigh any benefits against risks, to give them the full scoop, and to help them realize that most medications will not fix what ails them. I’m finally in a position to find out more about why they actually “need” medications in the first place, so that maybe we can work on habits around food, exercise, sleep, and stress that will eventually enable them to taper off prescription drugs.

Now I believe that I did choose the right profession, it just took a while to find out how to use my professional training in the right way.

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

$
Select Payment Method
Loading...
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Donation Total: $20.00

28 COMMENTS

    • I was asking myself the same thing, am I choosing the wrong profession when I started taking the classes to be a substance abuse counselor.

      Its a noble thing to do helping people but I would have to play along with so much stuff I don’t agree with and spend most of my time doing pointless paperwork for the stupid state, the insurance companies and no doubt be in trouble all the time for telling clients don’t take that crap there is nothing wrong with your damn serotonin, the never was explaining it and clashing with the doctors.

      Another thing I would be expected to do would be talk to probation officers, the first time one of them talked stupid to me I would just be like listen Mr typical low IQ authoritarian, addiction is not a crime and you can go to hell now and take your mass incarceration profiteering friends with you.

      I still might finish and take the test but I don’t think I want an official job at a drug rehab.

  1. You’re causing too much problems when you use your years of education to do evil.

    Your oath is to do no harm, and if you can’t solve for societal problems that cause people to suffer from lack of healthy food, exercise, sleep, and too much stress then you are part of the problem.

    You are a pharmacist, not a politician, health coach, social worker, mental health counselor, etc..

  2. Hey Mrs Amy Beausang ex-pharmacist

    Nice one. Years ago I got put under pressure again to stop resisting the brain disabling treatments, after suffering brain disabling treatments. This culminated in a pharmacist coming to visit me at my home. This was one of the most bizarre conversations I have ever had in my life.

    Why did it require three medical doctors and a science journalist to open your eyes?

    Surely you would have seen in front of your eyes the rapid deterioration in the person swallowing the brain disabling treatments?

    As an aside I have deliberately avoided a tacky joke here based upon your profile photo.

    But anyway, it’s always good to see someone find their conscience and bail out. And I wish you the best. All I’d add is that you do a little bit more in a kind of spiritual service to those people you leave behind you who you have contributed in brain disabling and so on. This would be of some kind of voluntary work. There is soul-damage, in all directions. It’s not something that should just be walked away from.

  3. Very insightful narrative, Amy, thank you. And absolutely, those of us who know about, and understand, the scientific fraud going on within the psycho / pharmacutical industries do need to rock the boat. We all need to work to change the system by trying to educate others. Thanks for doing so, Amy, and keep going!

    And I’m trying to do this, too. For example, this weekend I was at a family funeral, not a pleasant reason for a family get together, but it was really nice to see everyone. While there, I had a little chat with the wife of a long time family friend, she’s a psychiatrist. We got chatting about psychiatry and she told me NAMI was a great organization. I said I’d heard it was a pharmaceutically funded front group. She was shocked, and said she had no idea, am I incorrect? She then mentioned she worked with veterans. I said I was heartbroken by the staggeringly high suicide rates of veterans in recent years. She was quick to say suicides were a problem for all within society.

    http://www.latimes.com/nation/la-na-veteran-suicide-20150115-story.html

    I apparently looked at her in a skeptical manner. So she went on to explain that since we’re in the midst of an unpopular war, this was the root cause of the high suicide rates within the military. I asked if it might be possible the root cause was all the fraudulent science and marketing of toxic and harmful drugs by the pharmacutical industry in recent years instead? She looked at me puzzled, and said nothing.

    So I changed the subject and asked her if she was aware of the childhood bipolar epidemic. And to be diplomatic, I stated I understood it was likely largely caused by miseducated PCPs. She conceded she was aware of the epidemic, but reminded me she worked with veterans. I asked her if she was aware of the fact it was an almost completely iatrogenic epidemic. Again, a puzzled look, but in her defense she was unaware of the fact I was a psycho / pharmacutical industry researcher prior to this time.

    Then I mentioned my concern regarding today’s psychiatric industry’s “bipolar” drug cocktail recommendations. I reminded her they include combining the antidepressants and antipsychotics, which is already medically known to make these poor children “psychotic,” via anticholinergic toxidrome. Again, no comeback. We amicably parted ways.

    https://en.m.wikipedia.org/wiki/Toxidrome

    It’s interesting speaking with a psychiatrist on an equal basis, in an ‘all people are created as equals’ basis. Rather than in the warped, power imbalanced basis set up by the psychiatric industry. When one does this, the psychiatrists (including my prior ones) come across as clueless or unethical people, totally unaware and / or incapable of actually addressing the real issues going on within their industry. Robert Whitaker calls it cognative dissidence.

    I don’t think this family friend psychiatrist means any harm to her patients, although harm is being done to the military by the military psychiatrists, in general. But I do hope our conversation helps to wake her up, I hope it encourages her to do some research. If nothing else, figure out why a bankers’ daughter / kitchen / bath designer knows more about her industry, than does she.

    Although her father-in-law did defraud my family, by claiming the ELCA was a Christian religion, out of millions in cash and services kindly rendered to the ELCA religion by my family. Prior to standing 100% in support of covering up the abuse of my child, via “the dirty little secret of the two original educated professions.” So maybe, God is on my side, which is what gave me the advantage? Who knows? But others are also disgusted by the recent sins of the leaders of the ELCA.

    https://books.google.com/books?id=xI01AlxH1uAC&printsec=frontcover&source=gbs_ge_summary_r&cad=0#v=onepage&q&f=false

    We all have to wake the psychitrists up to the harm they are doing, many do seem clueless. And the banking and pharmaceutical cartels need to be broken up. We need to bring about a competitive market worldwide in all industries, rather than succumbing to the “central banks, and corporation that will grow up around them,” of which Thomas Jefferson forewarned us.

    https://www.monticello.org/site/jefferson/private-banks-quotation

    The Rothschild’s / Rockefellor’s dynasty goals of the UN takeover of the world are not in the best interests of anyone on this planet, other than themselves. The ethical American bankers’ families did responsibly manage the money, and assist in making this country great, prior to these fiscally irresponsible “too big to fail” banks usurping and destroying our country.

    I’m glad you’ve found your way Amy, pray I do too, I’m working on it.

    • Did you get the sense that the psychiatrist you were chatting with had her interest piqued and was going to go investigate any of this? Or was it more a polite nod and “Huh, how interesting”?

      And I hate NAMI as much as the next activist but I think them receiving Big Pharma money is not the issue to focus on. It’s their abhorrent policies that really need attacking.

  4. Hi, I like your article.

    I see different solutions on offer for depression like:- ECT, Lithium, Electrical Stimulation, Ketamine, SSRIs etc.

    My definition of depression would be, to be so depressed as not to be able to go out and buy food, and to starve to death – but I did suffer from terrible misery or dysphoria when I withdrew from my mefication. Meditation worked for me here and my misery never returned.

    I also suffered from terrible “high anxiety” on medication withdrawal and the buddhist detachment principle worked for me (through showing me a different approach to my anxiety).

    The statins must be one of the most ‘inventive’ creations within medicine – imagine telling every middle aged man that his blood is too fatty and that he could well have a heart attack, but that taking a pill everyday would prevent this (and roping the other interested parties in as well).

  5. No. You did not choose the wrong profession. I have been initiated into The Way of Madness and I can tell you with absolute certainty that you didn’t choose the wrong profession. You chose the wrong drugs. What you should have been dispensing to the lost souls who presented themselves to you were the hallucinogenic drugs, particularly, for those suffering the travails we have come to call schizophrenia, you should have taken the into a back room and humanely administered ayuasca, and, as the sick bucket filled, know in your heart of hearts that you were taking part in a ritual that was going to save the world.

    This is backed up by sound and rational science. And if anyone questioned what the hell was going on, all you had to say was, Seth Farber told you so.

    I truly despair. Although thankfully have a sense of humour as my spiritual guide. Help me!

    • Sorry, “rasselas”, but ayuasca will only ever be an appropriate herbal treatment for a minority of persons, and then only after classes in it’s proper use, ethnobotany, etc., and a proper setting. For some, ayuasca would be WORSE than psych drugs….
      We don’t have literally 10’s of millions of cannabis users because it’s so “harmful”….
      You know as well as I do, that PhRMA is all about making $$$$….
      Yes, and they will sicken MILLIONS to do it….
      But hey, at least Amy didn’t go into the pseudoscience LIES of the DRUG RACKET known as “biopsychiatry”…..She’s only a minor-level drug dealer…. Licensed & educated as such….
      Glad you’re here, Amy! Welcome!…. Can you hook me up with so0me clonazepam? ~B./

      • Hi “Bradford”

        Are the pseudo-quotes some new convention? Or is it another of the microaggressions?

        You typed:

        “but ayuasca will only ever be an appropriate herbal treatment for a minority of persons, and then only after classes in it’s proper use, ethnobotany, etc., and a proper setting. For some, ayuasca would be WORSE than psych drugs….”

        Who gets to decide? And how? I’ll answer the question for you. The person that gets to decide who is best suited and who is not, is a con artist.

        I find it remarkable (admittedly, only a teeny weeny bit) that people rail against the lack of robust assessment in psychiatry, yet embrace so willingly the quackery that is “alternative”, especially when it comes to ayuasca.

        You typed:

        “We don’t have literally 10’s of millions of cannabis users because it’s so “harmful”….
        You know as well as I do, that PhRMA is all about making $$$$….
        Yes, and they will sicken MILLIONS to do it….”

        Well, it is a capitalist environment. I don’t think making money is something to point the finger at. Are you telling me the New Age con artists are not making money? Are the sellers of alcohol and cannabis not making money?

        And just because lots of people use a drug — for instance nicotine — doesn’t in and of itself prove it mustn’t be harmful. If only human beings were actually that rational we wouldn’t be in such a mess, would we?

        And finally you had a dig at the ex-pharmacist for involving herself in the drugs trade. Which is a cheap shot. Although if she’s going to back-hand you some clonazepam I think it only fair she throws me a couple of kilos of codeine…

      • He contributes here. He’s an intelligent man. Make no mistake. However, I don’t see eye to eye with him and his kin.

        They believe that people that come to be known as schizophrenic or manic are in fact in posession of a dangerous healing gift known as shamanism. The shaman is a New Age western construct. In a nutshell, it is a form of cultural appropriation or ransacking of the many thousands of indiginous/traditional cultures of the world. They take a bit from here and a bit from there and believe they are passported into doing this through the German quesi-mystic Carl Jung, who introduced the West to a new idea called Collective Consciousness. This basically gives thumbs up to cultural pilfering, depicting all the private traditions of the world as non-private resources for westerners to ransack, as spiritual tourists.

        In recent times such Jungian-passported spiritual colonialists/tourists have been debasing Peruvian culture as a kind of adventure holidaying cure to western sadness.

        That’s all I wish to say on the matter. Seth would obviously beg to differ but I doubt he’d want to waste his orgone on a deadbeat like me. 😉

      • Circa, are you responding to me?

        In the US we have a huge untouchable caste which lives a very marginalized existence, often consisting of alcohol, drugs, and psychiatric medication, while sleeping in shelters or under bridges, or in Recovery Programs.

        It is all abuse, because people who have been treated with dignity and respect and who have been given the chance to develop and apply their abilities would not be susceptible to alcohol, drugs, psychiatry, or psychotherapy.

        It is all predicated on the ways that the middle-class family is allowed, and expected, to exploit and abuse children.

        You wrote,

        “I don’t understand your comment. How is empowering patients to assess/manage their health care “doing evil”? ”

        Empowering patients to manage their health care is doing evil if it is all based on fallacious premises, non-existent illnesses and ailments. This is how psychotherapy and psychiatry work, what we used to call Munchausen’s by Proxy, but that we now just call Medical Child Abuse. Children are being convinced that there is something wrong with them. And so as this is being done over and over and over, they believe it, and they end up in this huge untouchable caste.

        As Capitalism no longer needs so much cheap labor, it looks to The Family to provide scapegoats to subject to ritual humiliations in order to maintain compliance.

        Nomadic
        http://freedomtoexpress.freeforums.org/must-reject-psychotherapy-it-is-just-like-drugs-t304.html

  6. Great article Amy! There is this disturbing feeling a lot of us in the medical profession have about the current state of health care. Is it all about money? Are we just pawns in a system? It’s a modern day variation on the story “The Emperors New Clothes.” This article sums it up very well.

  7. Amy, I thank you for an insightful article but I would like you to hear my story concerning the results of all that successful advertising. It appears to be quite cathartic for you to reveal all the duplicity and deception that goes on in the big pharma/medical community in bringing a drug to market but you must excuse my lack of compassion. I sit here after a 2 year horrendous taper/withdrawal from lorazepam, literally shaking with anger. I happen to be the poster child for the benzodiazepine withdrawal syndrome. I was told by my (ex) psychiatrist and GP that I would need these drugs (Inderal, Pamelor, and Xanax/Klonopin/Ativan) for the rest of my life. I believed them because they were the M. Deity. I’m lucky that I only lost 2 years of my life. My older brother did not fare as well. He was put on Valium and Elavil with the same ridiculous line from his doctor(s). He murdered his wife in 2003 and is in prison for the rest of his life. Do you understand what true grief is? Our families have been forever shattered and nothing will ever change that. It’s comforting to know that so much time and money is being spent to literally ruin people’s lives. I do not share your career angst/regret. I live with a more painful reality than you could ever imagine.